Follow up of breast cancer GWAS through drug repositioning and CRISPR screens
Status: This talk is in preparation - details may change
Bio: Professor Georgia Chenevix-Trench is Distinguished Scientist at the Queensland Institute of Medical Research in Brisbane, Australia, and Fellow of the Australian Academy of Sciences. She is the author of more than 500 peer-reviewed papers, and has been instrumental in the collection of public resources such as kConFab, the Australian consortium for research into familial breast cancer. She founded the international Consortium of Investigators of Modifiers of BRCA1/2, and is a founding member of the Breast Cancer Association Consortium, which together have identified over 200 breast cancer susceptibility loci since the advent of genome-wide association studies. The major focus of her current research is to identify the target genes at these loci though functional CRISPR screens, and to identify opportunities for drug repositioning.
Date:
11 July 2024, 9:30 (Thursday, 12th week, Trinity 2024)
Venue:
Wellcome Trust Centre for Human Genetics, Headington OX3 7BN
Venue Details:
Seminar room B
Speaker:
Prof Georgia Chenevix-Trench (QIMR Berghofer Medical Research Institute)
Organising department:
Big Data Institute (NDPH)
Organisers:
Nicola Whiffin (University of Oxford),
Duncan Palmer (University of Oxford)
Organiser contact email address:
sumeeta.maheshwari@ndph.ox.ac.uk
Host:
Prof Naomi Wray (University of Oxford)
Part of:
BDI/CHG Genomics Seminar Series
Booking required?:
Not required
Audience:
Members of the University only
Editor:
Sumeeta Maheshwari
